Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 74-80
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.74
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.74
Table 2 Mean volumes to measure gastric accommodation by scintigraphy using ANCOVA adjusted for age and gender
| Mean (± SE) | Itopride | Placebo |
| Change in volume (post-pre) using scintigraphy | ||
| Fasting | -22.2 (± 15.4) | 7.5 (± 14.9) |
| 20 min | -201.7 (± 102.4) | -31.5 (± 99.1) |
| 30 min | 0.14 (± 22.8) | -36.4 (± 22.1) |
| 40 min | -27.6 (± 32.2) | -37.4 (± 31.2) |
| 50 min | -60.0 (± 31.2) | -3.0 (± 30.2) |
| 60 min | -3.1 (± 36.5) | 15.0 (± 35.4) |
| 90 min | 3.8 (± 29.8) | -31.8 (± 28.8) |
| 120 min | 16.7 (± 28.9) | 23.3 (± 28.0) |
| Effect on gastric emptying on 13C labeled octanoic acid breath test (post-pre) | 0.4 (± 0.4) | 0.2 (± 0.4) |
| Effect on drinking capacity (post-pre) | 22.5 (± 18.1) | 36.0 (17.5) |
| Change in Symptom score (post-pre) | -5.8 (1.0) | -4.7 (0.9) |
- Citation: Abid S, Jafri W, Zaman MU, Bilal R, Awan S, Abbas A. Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia. World J Gastrointest Pharmacol Ther 2017; 8(1): 74-80
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/74.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.74